Document Type : Original Research


Department of Pathology, Dayanand Medical College & Hospital, Ludhiana, Punjab, India



Background & Objective: An accurate Ki-67 labeling index assessment is critical for managing a few tumors, like breast carcinomas and neuroendocrine tumors. We aimed to determine the degree of agreement between digital image analysis (DIA) & eye-rolling assessment (EE) and DIA & manual count (MC) for Ki-67 LI scoring.
Methods: A total of 120 cases (Both tru-cut biopsies and resected specimens) were selected during the study period from the institutional database wherein the Ki-67 labeling index was performed. The selected cases were divided into two groups, i.e., breast neoplasms and other neoplasms. The correlation between DIA & EE and DIA & MC for Ki-67 LI scoring was calculated in both groups.
Results: A total of 113 cases were analyzed for Ki-67 LI by three different methods (EE, MC, & DIA); 7 cases were rejected because of poor image quality. Ki-67 LI scoring by DIA & EE was highly correlated in both the study groups with a Spearman's rank correlation coefficient of 0.809 (P=0.01) and 0.904 (P=0.01), respectively. Correlation between DIA & MC methods was also found to be almost perfect in both study groups with a Spearman's rank correlation coefficient of 0.974 (P=0.01) and 0.955 (P=0.01), respectively.
Conclusion: ImmunoRatio is a free web-based digital image analysis application that can be used for Ki-67 LI assessment with considerable reliability and reproducibility. Yet, it carries a few limitations and demands a careful approach and final confirmation by an expert.


Main Subjects

  1. Kwon AY, Park HY, Hyeon J, Nam SJ, Kim SW, Lee JE, et al. Practical approaches to automated digital image analysis of Ki-67 labeling index in 997 breast carcinomas and causes of discordance with visual assessment. PLoS One. 2019;14(2):e0212309. [DOI:10.1371/journal.pone.0212309] [PMID]
  2. Perren A, Couvelard A, Scoazec JY, Costa F, Borbath I, Delle Fave G, et al. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pathology: Diagnosis and Prognostic Stratification. Neuroendocrinology. 2017;105(3):196-200. [DOI:10.1159/000457956] [PMID]
  3. Davey MG, Hynes SO, Kerin MJ, Miller N, Lowery AJ. Ki-67 as a Prognostic Biomarker in Invasive Breast Cancer. Cancers (Basel). 2021;13(17):4455. [DOI:10.3390/cancers13174455] [PMID]
  4. Owens R, Gilmore E, Bingham V, Cardwell C, McBride H, McQuaid S, et al. Comparison of different anti-Ki67 antibody clones and hot-spot sizes for assessing proliferative index and grading in pancreatic neuroendocrine tumours using manual and image analysis. Histopathology. 2020;77(4):646-58. [DOI:10.1111/his.14200] [PMID]
  5. Kroneman TN, Voss JS, Lohse CM, Wu TT, Smyrk TC, Zhang L. Comparison of Three Ki-67 Index Quantification Methods and Clinical Significance in Pancreatic Neuroendocrine Tumors. Endocr Pathol. 2015;26(3):255-62. [DOI:10.1007/s12022-015-9379-2] [PMID]
  6. Dowsett M, Nielsen TO, A'Hern R, Bartlett J, Coombes RC, Cuzick J, et al. Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group. J Natl Cancer Inst. 2011;103(22):1656-64. [DOI:10.1093/jnci/djr393] [PMID]
  7. Sundara Rajan S, Horgan K, Speirs V, Hanby AM. External validation of the ImmunoRatio image analysis application for ERα determination in breast cancer. J Clin Pathol. 2014;67(1):72-5. [DOI:10.1136/jclinpath-2013-201680] [PMID]
  8. Remes SM, Tuominen VJ, Helin H, Isola J, Arola J. Grading of neuroendocrine tumors with Ki-67 requires high-quality assessment practices. Am J Surg Pathol. 2012;36(9):1359-63. [DOI:10.1097/PAS.0b013e3182632038] [PMID]
  9. Fulawka L, Halon A. Proliferation Index Evaluation in Breast Cancer Using ImageJ and ImmunoRatio Applications. Anticancer Res. 2016;36(8):3965-72.
  10. Yeo MK, Kim HE, Kim SH, Chae BJ, Song BJ, Lee A. Clinical usefulness of the free web-based image analysis application ImmunoRatio for assessment of Ki-67 labeling index in breast cancer. J Clin Pathol. 2017;70(8):715-9. [DOI:10.1136/jclinpath-2016-204162] [PMID]
  11. Yamazaki Y, Nakamura Y, Shibahara Y, Konosu-Fukaya S, Sato N, Kubota-Nakayama F et al. Comparison of the methods for measuring the Ki-67 labeling index in adrenocortical carcinoma: manual versus digital image analysis. Hum Pathol. 2016;53:41-50. [DOI:10.1016/j.humpath.2015.10.017] [PMID]
  12. Xue T, Yu BH, Yan WH, Jiang XN, Tian T, Zhou XY et al. Prognostic significance of histologic grade and Ki-67 proliferation index in follicular lymphoma. Hematol Oncol. 2020;38(5):665-72. [DOI:10.1002/hon.2778] [PMID]